Price
$10.90
Increased by 0.00%
Dollar volume (20D)
22.68 K
ADR%
2.96
Shares float
896.02 K
Shares short
19.20 K [2.14%]
Shares outstanding
1.61 M
Market cap
18.13 M
Beta
1.33
Price/earnings
N/A
20D range
10.15 12.00
50D range
10.15 12.15
200D range
0.80 14.26

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.

The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates.

The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota.

Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Aug 13, 24 -3.01
Increased by +7.09%
-
May 10, 24 -2.41
Decreased by -535.21%
-
Mar 25, 24 -1.89
Decreased by -238.18%
-
Nov 8, 23 -1.51
Decreased by -77.09%
-
Aug 10, 23 -3.24
Decreased by -575.00%
-4.50
Increased by +28.00%
May 10, 23 -0.38
Increased by +26.92%
-0.09
Decreased by -322.22%
Mar 23, 23 -0.56
Decreased by -40.00%
-0.34
Decreased by -64.71%
Nov 10, 22 -0.85
Decreased by -304.76%
-0.40
Decreased by -112.50%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 24 0.00
Decreased by N/A%
-4.83 M
Increased by +30.45%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 2.85 M
Increased by +2.56 K%
-3.88 M
Increased by +93.94%
Decreased by -136.24%
Increased by +99.77%
Dec 31, 23 2.85 M
Increased by +35.46 K%
-3.04 M
Increased by +88.45%
Decreased by -106.89%
Increased by +99.97%
Sep 30, 23 0.00
Decreased by -100.00%
-2.42 M
Increased by +93.98%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by -100.00%
-6.95 M
Increased by +69.48%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 107.00 K
Decreased by -69.77%
-63.94 M
Decreased by -160.40%
Decreased by -59.76 K%
Decreased by -761.52%
Dec 31, 22 8.00 K
Decreased by -99.01%
-26.32 M
Decreased by -38.14%
Decreased by -329.02 K%
Decreased by -13.82 K%
Sep 30, 22 138.00 K
Decreased by -98.78%
-40.11 M
Decreased by -302.91%
Decreased by -29.07 K%
Decreased by -33.02 K%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY